19930513
 Ares-Serono SA   The Wall Street Journal,  May 14, 1993  Pharmaceuticals concern Ares-Serono SA said group net income for the first quarter fell 62% to 16.9 million Swiss francs ($11.6 million) from SFr44.7 million a year earlier. The drop was attributed to an extraordinary gain of SFr28.1 million in the year-earlier period.   
